romidepsin

histone deacetylase 9 ; Homo sapiens







33 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35039480 Blocking autophagy overcomes resistance to dual histone deacetylase and proteasome inhibition in gynecologic cancer. 2022 Jan 17 1
2 33079733 Vorinostat and fenretinide synergize in preclinical models of T-cell lymphoid malignancies. 2021 Jan 1 1
3 34893686 FK228 potentiates topotecan activity against small cell lung cancer cells via induction of SLFN11. 2021 Dec 10 1
4 30332940 Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents. 2020 1
5 30651077 Alterations in the glycome after HDAC inhibition impact oncogenic potential in epigenetically plastic SW13 cells. 2019 Jan 16 1
6 28972015 Synergy of BCL2 and histone deacetylase inhibition against leukemic cells from cutaneous T-cell lymphoma patients. 2017 Nov 9 1
7 26827693 The safety profile of vorinostat (suberoylanilide hydroxamic acid) in hematologic malignancies: A review of clinical studies. 2016 Feb 1
8 27318982 Synthesis and biological evaluation of novel FK228 analogues as potential isoform selective HDAC inhibitors. 2016 Oct 4 2
9 27470351 Histone deacetylase inhibitor, Romidepsin (FK228) inhibits endometrial cancer cell growth through augmentation of p53-p21 pathway. 2016 Aug 4
10 26043217 Belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma. 2015 1
11 26053117 Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage. 2015 Aug 1
12 18821579 Induction of autophagy in malignant rhabdoid tumor cells by the histone deacetylase inhibitor FK228 through AIF translocation. 2009 Jan 1 3
13 18971205 Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition. 2009 Jan 15 3
14 19200053 The changing face of HDAC inhibitor depsipeptide. 2009 Feb 2
15 19322073 Acquired vorinostat resistance shows partial cross-resistance to 'second-generation' HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities. 2009 Jun 2
16 18416310 Histone deacetylase inhibitors from microorganisms: the Astellas experience. 2008 2
17 17671692 The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells. 2007 Sep 2
18 16186804 Histone deacetylase inhibitor FK228 suppresses the Ras-MAP kinase signaling pathway by upregulating Rap1 and induces apoptosis in malignant melanoma. 2006 Jan 26 2
19 16418572 Sichuan pepper extracts block the PAK1/cyclin D1 pathway and the growth of NF1-deficient cancer xenograft in mice. 2006 Mar 2
20 16424655 Histone deacetylase inhibitor depsipeptide (FK228) induces apoptosis in leukemic cells by facilitating mitochondrial translocation of Bax, which is enhanced by the proteasome inhibitor bortezomib. 2006 2
21 16435156 FK228 (depsipeptide): a HDAC inhibitor with pleiotropic antitumor activities. 2006 Nov 1
22 16888791 Histone deacetylase inhibitor FK228 is a potent inducer of human fetal hemoglobin. 2006 Dec 1
23 15515013 Involvement of the tumor necrosis factor (TNF)/TNF receptor system in leukemic cell apoptosis induced by histone deacetylase inhibitor depsipeptide (FK228). 2005 May 2
24 15791453 Effects of histone deacetylase inhibitor FR901228 on the expression level of telomerase reverse transcriptase in oral cancer. 2005 Jul 3
25 15833893 Chemoresistance to depsipeptide FK228 [(E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8,7,6]-tricos-16-ene-3,6,9,22-pentanone] is mediated by reversible MDR1 induction in human cancer cell lines. 2005 Jul 1
26 15914281 Significant growth suppression of synovial sarcomas by the histone deacetylase inhibitor FK228 in vitro and in vivo. 2005 Jun 28 4
27 15063388 Effects of demethylating agent 5-aza-2(')-deoxycytidine and histone deacetylase inhibitor FR901228 on maspin gene expression in oral cancer cell lines. 2004 Jul 2
28 15078940 Apoptosis induced by the histone deacetylase inhibitor FR901228 in human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells. 2004 May 3
29 15171260 Histone deacetylase inhibitors: development as cancer therapy. 2004 1
30 12569581 Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small-cell lung cancer lines and drug-resistant sublines. 2003 Mar 20 3
31 12642691 The histone deacetylase inhibitor FR901228 (desipeptide) restores expression and function of pseudo-null p53. 2002 Nov-Dec 3
32 12678732 Histone deacetylase inhibitors and anticancer therapy. 2002 Jul 2
33 11443220 Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of the Na(+)/I(-) symporter and iodine accumulation in poorly differentiated thyroid carcinoma cells. 2001 Jul 3